Rankings
▼
Calendar
VERA
Vera Therapeutics, Inc.
$3B
FY 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$509,000
Operating Income
-$12M
Net Income
-$12M
EPS (Diluted)
$-3.46
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$263,000
Balance Sheet
Total Assets
$5M
Total Liabilities
$42M
Stockholders' Equity
-$37M
Cash & Equivalents
$3M
← Q1 2020
All Quarters
VERA FY 2019 Earnings — Vera Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
